新たに診断された多形性膠芽腫患者の治療におけるホウ素中性子捕捉療法、放射線療法、およびテモゾロミド

基本情報

NCT ID: NCT00974987
ステータス: 完了
試験のフェーズ: 第2相
試験タイプ: 介入
目標被験者数: 32
治験依頼者名: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

概要

RATIONALE: Boron neutron capture therapy and radiation therapy use high-energy x-rays and other types of radiation to kill tumor cells. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving boron neutron capture therapy followed by radiation therapy and temozolomide may kill more tumor cells. PURPOSE: This phase II trial is studying the side effects of giving boron neutron capture therapy together with radiation therapy and temozolomide in treating patients with newly diagnosed glioblastoma multiforme.

対象疾患

Brain and Central Nervous System Tumors

介入

BNCT(boron neutron capture therapy)(RADIATION)

XRT(X-ray radiation treatment)(RADIATION)

TMZ(temozolomide)(DRUG)

依頼者（Sponsor）

Translational Research Center For Medical Innovation, Kobe, Hyogo, Japan(OTHER)

Department Of Nuerosurgery, Osaka Medical College(UNKNOWN)

実施施設 (1)

大阪医科薬科大学病院

Takatsuki, Osaka, Japan